Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial

BACKGROUND: Despite the reported health effects of cardamom on dyslipidemia, hepatomegaly, and fasting hyperglycemia, no human research has studied its potency in non-alcoholic fatty liver disease (NAFLD) as the hepatic part of metabolic syndrome. Our aim was determining the effects of green cardamo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Complement Altern Med
Asıl Yazarlar: Daneshi-Maskooni, Milad, Keshavarz, Seyed Ali, Qorbani, Mostafa, Mansouri, Siavash, Alavian, Seyed Moayed, Badri-Fariman, Mahtab, Jazayeri-Tehrani, Seyed Ali, Sotoudeh, Gity
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6419418/
https://ncbi.nlm.nih.gov/pubmed/30871514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-019-2465-0
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller